Stay updated with breaking news from California inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TD Cowen Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $2.50 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its target price trimmed by Sanford C. Bernstein from $9.00 to $2.50 in a research note released on Thursday morning, Benzinga reports. The firm currently has an outperform rating on the biotechnology company’s stock. A number of other equities research analysts have also recently commented on […] ....
Barclays Cuts Pacific Biosciences of California (NASDAQ:PACB) Price Target to $3.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $7.00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.